Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)

You may be eligible if

• DISEASE CHARACTERISTICS:
• Meets 1 of the following criteria:
• * Patients at the University of California, San Francisco Breast Care Center meeting the following criteria:
• * Biopsy proven ductal carcinoma in situ (DCIS) of the breast.
• * Has undergone mammography within the past 60 days.
• * ADH patients: over 18, no prior history of breast disease.
• PATIENT CHARACTERISTICS:
• Referrals to this trial are through breast care clinicians only
• Not pregnant or nursing (or stopped nursing within the past 3 months)
• Negative pregnancy test
• No contraindication to MRI (e.g., implanted pacemaker, implanted ferromagnetic device, ferromagnetic aneurysm clip, severe claustrophobia, ocular metal fragments, or shrapnel injury)
• PRIOR CONCURRENT THERAPY:
• More than 2 years since prior surgery to the ipsilateral breast (patient)
• No prior radiotherapy to the ipsilateral breast (patient)
• No prior cytotoxic regimens (patient)